Drug Trial Radar · NCT06380699
Study to Assess PK, Safety and Tolerability in Healthy Subjects
Last checked: Nov 19, 2026Latest source record: Jul 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
56
Actual
Start
Mar 16, 2023
Primary completion
Nov 16, 2023
Study completion Dec 25, 2023
Sponsor
- Lead sponsor
- Changzhou Qianhong Bio-pharma Co., Ltd.Industry
- Sponsor type
- Industry
- First posted
- Apr 24, 2024
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Other
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years, up to 50 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
The purpose of this study is to assess the safety, tolerability, pharmacokinetics (PK) and pharmacodynamics (PD) of QHRD106 in Chinese healthy subjects with single and multiple doses.
Conditions
- Acute Ischemic Stroke
Interventions
QHRD106 InjectionDrug
PEG-tissue kallikrein-1
Human Urinary KallidinogenaseDrug
tissue kallikrein-1
placeboDrug
placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety as assessed by incidence, severity, and causality of adverse eventsTime frame: Up to 43 days after final dose
- Plasma measurements of QHRD106Time frame: Up to 43 days after final dose
- Concentration of bradykinin in plasmaTime frame: Up to 43 days after final dose
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Nanjing Drum Tower Hospital
Nanjing, Jiangsu, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.